← Leaderboards
Maria Flynn
Orbis Biosciences, Inc.
$258,353
Attributed
$948,851
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $599.4K · FY2010–11$1M$750K$500K$250K$0
'10
'11
Funding mix
By agency
NIH$948,851 · 2
By mechanism
R43$948,851 · 2
Top collaborators
- Cory Berkland3 shared
- Ronald Arthur Beyerinck2 shared
- David N. Newbold2 shared
- Milind Singh1 shared
Most similar at Orbis Biosciences, Inc.
Same institution · by research overlap
- Nathan H Dormer$4,888,977
- Ronald Arthur Beyerinck$173,793
- David N. Newbold$173,793
- Milind Singh$210,328
- David Dumbauld$125,769
Others in their field
Top investigators on “Solutions”
- Gary Craft · Ch2m Hill Constructors, Inc$155,196,016
- David Heimbrook · Leidos Biomedical Research, Inc.$144,050,416
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$87,858,851
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$72,775,159
- Joseph B Martin · Harvard University (Medical School)$72,035,324
Research focus
SolutionsParticleMarketingProductionTechnologyDoseInnovationIn VivoPharmaceutical PreparationsPositioning AttributeValidationCharacteristicsPharmacologic SubstanceBusinessesEncapsulatedIndustryControlled ReleaseCostBeveragesChildhoodFailure (Biologic Function)Drug DevelopmentBedsEquipment
Grant awards (3)
Expanding Precision Particle Fabrication Technology for the Widespread Control of$345,672
R43 · FY2011 · RR · contact PI
Multi-day Pain Management Therapy with Novel Injectable Formulation$253,678
R43 · FY2011 · DA · contact PI
Expanding Precision Particle Fabrication Technology for the Widespread Control of$349,501
R43 · FY2010 · RR · contact PI